HBIO icon

Harvard Bioscience

90 hedge funds and large institutions have $107M invested in Harvard Bioscience in 2022 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 29 increasing their positions, 30 reducing their positions, and 26 closing their positions.

Holders
90
Holders Change
-8
Holders Change %
-8.16%
% of All Funds
1.52%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
21
Increased
29
Reduced
30
Closed
26
Calls
$1K
Puts
Net Calls
+$1K
Net Calls Change
-$27K
Name Market Value Shares Shares
Change
Shares
Change %
MIM
101
MetLife Investment Management
New Jersey
-16,835 Closed
California State Teachers Retirement System (CalSTRS)
102
California State Teachers Retirement System (CalSTRS)
California
-16,749 Closed
Invesco
103
Invesco
Georgia
-14,406 Closed
LSAG
104
Lake Street Advisors Group
New Hampshire
-12,479 Closed
ProShare Advisors
105
ProShare Advisors
Maryland
-11,590 Closed
AIMCA
106
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
-11,386 Closed
Mackenzie Financial
107
Mackenzie Financial
Ontario, Canada
-10,536 Closed
Barclays
108
Barclays
United Kingdom
-6,378 Closed
AB
109
Amalgamated Bank
New York
-6,198 Closed
Legal & General Group
110
Legal & General Group
United Kingdom
-3,851 Closed
AIP
111
Ameritas Investment Partners
Nebraska
-3,333 Closed
MLICM
112
Metropolitan Life Insurance Company (MetLife)
New York
-2,766 Closed
Royal Bank of Canada
113
Royal Bank of Canada
Ontario, Canada
$0 8 -2,406 -100%
FAG
114
Fortitude Advisory Group
Washington
-500 Closed
CFGS
115
Concourse Financial Group Securities
Alabama
Group One Trading
116
Group One Trading
Illinois
CS
117
Credit Suisse
Switzerland
$0 21 +21 New
BTI
118
Blue Trust Inc
Georgia
$0 36 +36 New
Simplex Trading
119
Simplex Trading
Illinois
$0 235 +235 New